查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589562

利尿劑市場：按藥物類型、分銷管道、給藥途徑、應用分類 - 全球預測 2025-2030

Diuretics Drugs Market by Drug Type (Calcium Sparing Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics), Distribution Channel (Drug Stores, Hospital Pharmacies, Online Pharmacies), Route of Administration, Applications - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年利尿劑市值為11.9億美元，預計2024年將達到12.9億美元，複合年成長率為8.54%，預計到2030年將達到21.2億美元。

利尿劑通常被稱為水丸，是一種旨在增加腎臟排出水和鹽的藥物，對於治療高血壓、心臟衰竭和水腫相關疾病等多種疾病至關重要。對利尿劑的需求主要源自於其緩解液體儲存和降低血壓的能力，從而降低中風和心臟病發作的風險。利尿劑的用途涵蓋醫療和臨床環境，用於治療腎功能障礙和預防因積液過多而引起的併發症。最終用途範圍涵蓋醫院、診所、門診病人設施和家庭醫療保健環境。由於心血管疾病盛行率上升、老年人口增加以及生活方式相關疾病發生率增加，利尿劑市場預計將成長。關鍵的成長要素包括聯合治療，該療法將利尿劑與其他抗高血壓藥物結合以最佳化治療效果。特別是在長期高血壓治療中，有很大機會開發創新配方，以提高患者的依從性並最大限度地減少副作用。個人化醫療的推動也開啟了基於基因分析客製化利尿療法的可能性。然而，該市場存在局限性，例如電解質不平衡等潛在副作用以及醫藥品認證過程中的監管障礙。此外，副作用較少的替代療法的出現也是一個競爭挑戰。精準醫學和先進利尿劑的合成領域具有創新潛力，可提高治療效果並減少副作用併發症。製藥公司和生技公司之間的合作可以帶來藥物傳輸系統的突破。在持續研究和消費者對更安全、更有效的治療解決方案的需求的推動下，利尿劑市場仍然充滿活力，這使得持續創新和策略聯盟至關重要。

主要市場統計
基準年[2023] 11.9億美元
預測年份 [2024] 12.9億美元
預測年份 [2030] 21.2億美元
複合年成長率（%） 8.54%

市場動態：揭示快速發展的利尿劑市場的關鍵市場洞察

供需的動態交互作用正在改變利尿劑市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 腎臟和腎臟疾病盛行率上升
    • 世界老年人口的增加
    • 高血壓和高血壓治療的採用率增加
  • 市場限制因素
    • 與患者不良反應相關的風險
  • 市場機會
    • 開發和引進新治療方法
    • 政府對保健藥品生產的扶持措施
  • 市場挑戰
    • 監管機構的嚴格監管和合規

波特駕馭利尿劑市場的五種策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解利尿劑市場的外部影響

外部宏觀環境因素對利尿藥市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解利尿劑市場的競爭狀況

利尿劑市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣利尿劑市場供應商的績效評估

FPNV定位矩陣是評估利尿劑市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了利尿藥市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對利尿藥市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 腎臟疾病盛行率增加
      • 世界各地老年人口不斷成長
      • 高血壓治療的採用率增加
    • 抑制因素
      • 對患者產生不良影響的風險
    • 機會
      • 開發和引進新治療方法
      • 政府對保健藥品生產的扶持措施
    • 任務
      • 監管機構的嚴格監管和合規
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章：按類型分類的利尿劑市場藥物

  • 保鈣利尿劑
  • 碳酸酐酶抑制劑
  • 袢利尿劑
  • 低天花板利尿劑
  • 滲透性利尿劑
  • 保鉀利尿劑
  • 噻嗪類利尿劑藥房

第7章 利尿劑市場：依分銷管道

  • 藥局
  • 醫院藥房
  • 網路藥房
  • 零售藥房

第8章 利尿劑市場：依給藥途徑

  • 靜脈
  • 口服

第9章 利尿劑市場：依應用分類

  • 尿崩症
  • 浮腫
  • 高鈣尿症
  • 高血壓

第10章美洲利尿劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太利尿劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲利尿劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Amneal Pharmaceuticals LLC
  • Centaur Pharmaceuticals Pvt Ltd
  • Hikma Pharmaceuticals Inc.
  • Merck & Co., Inc.
  • Novartis International AG
  • Perrigo Pharmaceuticals Company
  • Sanofi SA
  • Zydus Lifesciences Limited
Product Code: MRR-4103B31E0594

The Diuretics Drugs Market was valued at USD 1.19 billion in 2023, expected to reach USD 1.29 billion in 2024, and is projected to grow at a CAGR of 8.54%, to USD 2.12 billion by 2030.

Diuretics drugs, often called water pills, are medications designed to increase the excretion of water and salts through the kidneys, making them a crucial component in managing various medical conditions, such as hypertension, heart failure, and edema-linked disorders. The necessity for diuretics primarily stems from their ability to alleviate fluid retention and lower blood pressure, thereby reducing the risks of strokes and heart attacks. Their application spans across medical and clinical environments for treating renal dysfunctions and preventing complications from excessive fluid buildup. The end-use scope covers hospitals, clinics, outpatient facilities, and home healthcare settings. The diuretics drug market is poised for growth due to the rising prevalence of cardiovascular disorders, increasing geriatric populations, and the expanding incidence of lifestyle-associated ailments. Key growth influencers include advancements in combination therapies integrating diuretics with other antihypertensives, optimizing treatment efficacy. Noteworthy opportunities lie in developing innovative formulations that improve patient adherence and minimize side effects, particularly for long-term hypertensive treatment. The push towards personalized medicine also opens possibilities for tailoring diuretic therapies based on genetic profiling. However, the market encounters limitations such as potential side effects like electrolyte imbalance and regulatory hurdles pertaining to drug approval processes. Furthermore, the emergence of alternative therapies that promise fewer adverse effects poses a competitive challenge. Innovation can thrive in the fields of precision medicine and in the synthesis of advanced diuretics that have fewer side complications while enhancing therapeutic effectiveness. Partnerships between pharmaceutical companies and biotechnology firms can lead to breakthroughs in drug delivery systems. The diuretics drug market remains dynamic, driven by ongoing research and consumer demand for safer and more effective therapeutic solutions, underscoring the imperative for continuous innovation and strategic collaborations.

KEY MARKET STATISTICS
Base Year [2023] USD 1.19 billion
Estimated Year [2024] USD 1.29 billion
Forecast Year [2030] USD 2.12 billion
CAGR (%) 8.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diuretics Drugs Market

The Diuretics Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of renal and kidney disorders
    • Growing geriatric populace globally
    • Increasing adoption to treat high blood pressure and hypertension
  • Market Restraints
    • Risks associated with negative impact on patients
  • Market Opportunities
    • Development and introduction of new therapies
    • Supportive government initiatives for healthcare drug manufacturing
  • Market Challenges
    • Strict regulations and compliance by regulatory bodies

Porter's Five Forces: A Strategic Tool for Navigating the Diuretics Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diuretics Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diuretics Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diuretics Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diuretics Drugs Market

A detailed market share analysis in the Diuretics Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diuretics Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diuretics Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diuretics Drugs Market

A strategic analysis of the Diuretics Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diuretics Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amneal Pharmaceuticals LLC, Centaur Pharmaceuticals Pvt Ltd, Hikma Pharmaceuticals Inc., Merck & Co., Inc., Novartis International AG, Perrigo Pharmaceuticals Company, Sanofi S.A., and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Diuretics Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Calcium Sparing Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics, Low Ceiling Diuretics, Osmotic Diuretics, Potassium-Sparing Diuretics, and Thiazide Diuretics Local.
  • Based on Distribution Channel, market is studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Route of Administration, market is studied across Intravenous and Oral.
  • Based on Applications, market is studied across Diabetes Insipidus, Edema, Hypercalciuria, and Hypertension.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of renal and kidney disorders
      • 5.1.1.2. Growing geriatric populace globally
      • 5.1.1.3. Increasing adoption to treat high blood pressure and hypertension
    • 5.1.2. Restraints
      • 5.1.2.1. Risks associated with negative impact on patients
    • 5.1.3. Opportunities
      • 5.1.3.1. Development and introduction of new therapies
      • 5.1.3.2. Supportive government initiatives for healthcare drug manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations and compliance by regulatory bodies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diuretics Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Calcium Sparing Diuretics
  • 6.3. Carbonic Anhydrase Inhibitors
  • 6.4. Loop Diuretics
  • 6.5. Low Ceiling Diuretics
  • 6.6. Osmotic Diuretics
  • 6.7. Potassium-Sparing Diuretics
  • 6.8. Thiazide Diuretics Local

7. Diuretics Drugs Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Drug Stores
  • 7.3. Hospital Pharmacies
  • 7.4. Online Pharmacies
  • 7.5. Retail Pharmacies

8. Diuretics Drugs Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Intravenous
  • 8.3. Oral

9. Diuretics Drugs Market, by Applications

  • 9.1. Introduction
  • 9.2. Diabetes Insipidus
  • 9.3. Edema
  • 9.4. Hypercalciuria
  • 9.5. Hypertension

10. Americas Diuretics Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Diuretics Drugs Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Diuretics Drugs Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Amneal Pharmaceuticals LLC
  • 3. Centaur Pharmaceuticals Pvt Ltd
  • 4. Hikma Pharmaceuticals Inc.
  • 5. Merck & Co., Inc.
  • 6. Novartis International AG
  • 7. Perrigo Pharmaceuticals Company
  • 8. Sanofi S.A.
  • 9. Zydus Lifesciences Limited

LIST OF FIGURES

  • FIGURE 1. DIURETICS DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. DIURETICS DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIURETICS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIURETICS DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DIURETICS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DIURETICS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIURETICS DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIURETICS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIURETICS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIURETICS DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIURETICS DRUGS MARKET SIZE, BY CALCIUM SPARING DIURETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIURETICS DRUGS MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIURETICS DRUGS MARKET SIZE, BY LOOP DIURETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIURETICS DRUGS MARKET SIZE, BY LOW CEILING DIURETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIURETICS DRUGS MARKET SIZE, BY OSMOTIC DIURETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIURETICS DRUGS MARKET SIZE, BY POTASSIUM-SPARING DIURETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIURETICS DRUGS MARKET SIZE, BY THIAZIDE DIURETICS LOCAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIURETICS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIURETICS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIURETICS DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DIABETES INSIPIDUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIURETICS DRUGS MARKET SIZE, BY EDEMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DIURETICS DRUGS MARKET SIZE, BY HYPERCALCIURIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIURETICS DRUGS MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 196. DIURETICS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. DIURETICS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023